Debut Plus

864

-19.35 -2.19%

17 Jul 2026

NSE Listed · Pharmaceuticals

Sudeep Pharma Limited (SUDEEPPHRM)

Volume: 7,768Avg Vol 1W: 71,482Avg Vol 1M: 1,11,54752W Range:524.05894.95
Market Cap₹9,809 Cr
Current Price₹864
Previous Close₹883.35
High / Low (52w)₹894.95 / ₹524.05
Volume7,768
Avg Vol (1W)71,482
Avg Vol (1M)1,11,547
Stock P/E56.72
Book Value₹78.21
Dividend Yield0%
ROE19.57%
ROA14.83%
Revenue (TTM)
Revenue Growth9.3%
Profit Margin26.92%
Total Debt₹40 Cr
Shares Outstanding11 Cr
Face Value₹1
EPS (TTM)₹15.31
P/B11.1
Debt / Equity0.21
50 DMA₹835.1
200 DMA₹699.31
Day change-2.19%
Price Chart
864 11.61% · 1Y
8845304.0Cr
2025-11-28
2026-07-17

20-day avg volume: 1.0L shares

Pros
  • Healthy return on equity of 19.6%.
  • Company is almost debt-free.
  • Revenue grew 31% YoY.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 57.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹149 Cr₹116 Cr₹158 Cr₹125 Cr₹163 Cr₹172 Cr₹182 Cr
EBITDA₹63 Cr₹39 Cr₹60 Cr₹46 Cr₹62 Cr₹63 Cr₹65 Cr
Net Profit₹49 Cr₹29 Cr₹44 Cr₹31 Cr₹46 Cr₹47 Cr₹49 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹126 Cr₹219 Cr₹350 Cr₹438 Cr₹465 Cr₹511 Cr
EBITDA₹26 Cr₹44 Cr₹70 Cr₹91 Cr₹179 Cr₹189 Cr
Net Profit₹18 Cr₹33 Cr₹50 Cr₹62 Cr₹133 Cr₹139 Cr
EPS128.02236.61356.015.7412.2812.78
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹131 Cr₹213 Cr₹344 Cr₹420 Cr₹514 Cr₹717 Cr
Total Liabilities₹50 Cr₹99 Cr₹180 Cr₹197 Cr₹158 Cr₹224 Cr
Equity₹81 Cr₹114 Cr₹163 Cr₹223 Cr₹356 Cr₹493 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹16 Cr₹46 Cr₹15 Cr₹71 Cr₹110 Cr₹89 Cr
Investing₹-22 Cr₹-40 Cr₹-38 Cr₹-50 Cr₹-49 Cr₹-79 Cr
Financing₹12 Cr₹13 Cr₹51 Cr₹-10 Cr₹-13 Cr₹53 Cr
Free Cash Flow₹16 Cr₹46 Cr₹15 Cr₹71 Cr₹110 Cr₹89 Cr
Shareholding
Promoter 76.15% Institutions 17.46% Public 6.39%
Efficiency & Working Capital
ROCE22.2%
Interest Coverage27.8
Dividend Payout
Debtor Days135 d
Inventory Days94 d
Payable Days44 d
Cash Conversion Cycle184 d
Working Capital Days228 d
Shareholding Details

As of 2026-06-30

Promoter76.2%
FII1.8%
DII15.6%
Institutions17.5%
Public6.4%
Promoter Pledge0%
No. of Shareholders35,695
Shareholding Pattern

Quarterly — figures in %. Latest 6 quarters.

PeriodJun 2025Nov 2025Nov 2025Dec 2025Mar 2026Jun 2026
Promoters91.1%76.2%76.2%76.2%76.2%76.2%
FIIs0%0.9%1.5%1.7%1.6%1.8%
DIIs0%14.8%14.8%17.6%18.1%15.6%
Public8.9%8.2%7.5%4.6%4.2%6.4%
Promoter Pledge0%0%0%0%0%0%
No. of Shareholders162,17,9822,17,98243,59936,50335,695
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Riva Resources Private LimitedShareholding of Promoter and Promoter Group40.4%4.56 Cr
Bhayani Sujit JaysukhShareholding of Promoter and Promoter Group21.2%2.39 Cr
Sujeet Jaysukh Bhayani HufShareholding of Promoter and Promoter Group5.7%64,60,747
Avani Sujeet BhayaniShareholding of Promoter and Promoter Group4.5%50,53,140
Shanil Sujit BhayaniShareholding of Promoter and Promoter Group4.5%50,25,000
Nuvama Crossover Opportunities Fund - Series IiiPublic Shareholding3%33,37,482
Nuvama Crossover Opportunities Fund - Series Iii A .Public Shareholding2.6%29,02,744
Nuvama Crossover Opportunities Fund - Series Iii B .Public Shareholding2.1%24,16,427
Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund A/c Axis Small Cap FundPublic Shareholding1.9%20,85,880
Mukul Mahavir AgrawalPublic Shareholding1.3%15,00,117
Sbi Healthcare Opportunities FundPublic Shareholding1.2%13,60,000
Jaysukh Jayantilal BhayaniShareholding of Promoter and Promoter Group0%0
Dipen Jaysukh BhayaniShareholding of Promoter and Promoter Group0%0
Urvir Jaysukh BhayaniShareholding of Promoter and Promoter Group0%0
Rhea Sujit BhayaniShareholding of Promoter and Promoter Group0%0
Anjana Rajendrabhai PatelShareholding of Promoter and Promoter Group0%0
Rajendra Chunilal PatelShareholding of Promoter and Promoter Group0%0
Vidhi Shanil BhayaniShareholding of Promoter and Promoter Group0%0
Inaraa Shanil BhayaniShareholding of Promoter and Promoter Group0%0
Alka Pravinchandra KotakShareholding of Promoter and Promoter Group0%0
Pravinchandra Talakshibhai KotakShareholding of Promoter and Promoter Group0%0
Harsh Pravinbhai KotakShareholding of Promoter and Promoter Group0%0
Dipen Jaysukh Bhayani HufShareholding of Promoter and Promoter Group0%0
Urvir Jaysukh Bhayani HufShareholding of Promoter and Promoter Group0%0
Pravinbhai Talkshibhai Thakkar HufShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Bhayani Sujit Jaysukh00%2026-06-30
Sujeet Jaysukh Bhayani Huf00%2026-06-30
Avani Sujeet Bhayani00%2026-06-30
Shanil Sujit Bhayani00%2026-06-30
Jaysukh Jayantilal Bhayani00%2026-06-30
Dipen Jaysukh Bhayani00%2026-06-30
Urvir Jaysukh Bhayani00%2026-06-30
Rhea Sujit Bhayani00%2026-06-30
Anjana Rajendrabhai Patel00%2026-06-30
Rajendra Chunilal Patel00%2026-06-30
Vidhi Shanil Bhayani00%2026-06-30
Inaraa Shanil Bhayani00%2026-06-30
Board of Directors
NameDesignationYear
Sujit J BhayaniChairman & Managing Director2025
Shanil Sujit BhayaniWhole-time Director2025
Ajay Shrirang KandelkarWhole-time Director2025
Samaresh PandaIndependent Director2025
S. RaghunandanIndependent Director2025
Reshma PatelIndependent Director2025
Sujit GulatiIndependent Director2025
Dimple MehtaCompany Sec. & Compli. Officer2025
Segments — Geography
RegionRevenueShare
India₹153 Cr43%
USA₹55 Cr15.4%
Others₹148 Cr41.6%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹1121111
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-23Dividend (1.5/- per share)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202667600339718
20263080000308
2026160033857
Company Information
Incorporated1989
ChairmanSujit J Bhayani
AuditorB S R & Co
Investor Email[email protected]
🌐 www.sudeeppharma.com

📍 129/1/A GIDC Estate Nandesari, Vadodara, Gujarat, 391340

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search